Researchers have been excited about the medication , a innovative dual agonist showing remarkable data in clinical trials for weight management. It works by targeting several systems: GLP-1 and GIP, which , when activated , help influence appetite and enhance calorie burn. Preliminary findings demonstrate noteworthy size loss and potential advantag